Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s diseaseMathias Jucker, Elke Kuder-Buletta, Christian la Fougère et al.|Nature Medicine|2019Cited by 948
White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer networkSeonjoo Lee, Fawad Viqar, Molly E. Zimmerman et al.|Annals of Neurology|2016Cited by 553
24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trialHilkka Soininen, Noel Ellison, Alina Solomon et al.|The Lancet Neurology|2017Cited by 244
Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer DiseaseEdmond Teng, Carlo de Lena, Paul T. Manser et al.|JAMA Neurology|2022Cited by 188
Preferential degradation of cognitive networks differentiates Alzheimer’s disease from ageingJasmeer P. Chhatwal, Aaron P. Schultz, Keith A. Johnson et al.|Brain|2018Cited by 106